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IMPACT OF SMOKING ON ADULTS LUNG AGE AND VENTILATORY
FUNCTION
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Background: Although a large body of evidence exists on the effect of smoking on lung age and pulmonary
function, much less attention has been dedicated to using these effects as an effective strategy in smoking
cessation.
Objective: The present study was carried out to investigate the impact of smoking on lung age and ventilatory
function in adult Saudi in order to use these effects in a future strategy for smoking cessation.
Methods: Eighty one smoker students with their mean age 23.88 ± 2.7 years were enrolled in this study. Every
student  performed a ventilatory function tests  in order to measure lung age, forced vital capacity (FVC), forced
expiratory volume at the end of the first second (FEV1), FEV1/FVC ratio and peak expiratory flow rate PEFR.
Results:  The result showed significant deterioration in the mean value of FEV1, PEFR and the estimated lung
age and a non-significant difference in the mean values of FVC.
Conclusion: Smoking has a significant effect on ventilaroty function and deteriorating estimated lung age.
KEYWORDS: Smoking, Lung Age, Ventilatory function.
 Quick Response code
                                          Access this Article online
International Journal of Physiotherapy and Research
ISSN 2321- 1822
www.ijmhr.org/ijpr.html




Address for correspondence: Dr. Omar Farouk Helal, PT, Assistant Professor, Physical Therapy
Department, Faculty of Applied Medical Sciences, Umm Al Qura University. KSA.
Email: dr.mon5@hotmail.com
International Journal of Physiotherapy and Research,
Int J Physiother Res 2014, Vol 2(2):453-59.   ISSN 2321-1822
Peer Review: 24-02-2014
Cigarette smoking is a major health problem that
is responsible for a wide range of preventable
health problems throughout the world. It is
estimated that over the next 20 to 30 years,
cigarette smoking will result in 10 million deaths
annually on a worldwide basis, of which 70% will
occur in developing countries. 1
The World health organization reported that
tobacco smoking killed 100 million people
worldwide in the 20th century and warned that
it could kill one billion people around the world
in the 21st century. 2
Adolescent and teenage smoking has been
studied widely, and it has been found in
developing countries that nearly one-half of
school students who have reached the age of
18 have already established the habit of smoking
with some degree of regularity, and it is a rather
unrealistic hope on the part of adults to expect
that children will abstain until reaching the adult
approved age of decision. 3
Cigarette smoke is a complex mixture of more
than 4000 chemicals, many of which exert toxic
effects on cellular function and consider it as the
single most important risk factor for developing
chronic obstructive pulmonary disease (COPD).
These obstructions in airways invariably affect
the parameters of pulmonary function, e.g.
forced vital capacity (FVC), Forced Expiratory
Volume in the First Second (FEV1) and Peak
Expiratory Flow Rate. 4
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MATERIALS AND METHODS
Studies of pulmonary function among
asymptomatic smokers have demonstrated that,
as a group, they show significant impairment of
almost all parameters of lung function, especially
those indicating airway obstructions, as
compared to matched groups of nonsmokers. 5
Acute cigarette smoke has a suppressive effect
on the number of eosinophils and several
inflammatory cytokines, possibly due to the anti-
inflammatory effect of carbon monoxide. 6
In 2005, Selim and Al-Rushood 7 stated that
according to  recent year for which official data
are available, Saudi Arabia imported 36.5 million
kg of tobacco, costing an estimated 979 million
Saudi riyals (260.64 million US dollars) for a
population of about 15 million people. Lung
cancer, a smoking-related disease, is a leading
cause of cancer deaths among Saudi males,
suggesting that cigarette smoking is becoming
an important public health problem among men
in Saudi.
Smoking cessation is the only effective
treatment, slowing down the accelerated decline
in ventilatory function. One strategy to motivate
smokers to quit is to assess whether they have
abnormal lung function, which is a strong
independent risk factor for chronic obstructive
pulmonary disease (COPD), lung cancer,
cardiovascular disease, stroke, and all-cause
mortality. 8
One way to discuss abnormal lung function
results with patients is to use, the lung age
concept, which relates a person’s current lung
function, to the age at which his/her lung
function would be considered normal. Thus, an
elevated lung age signifies poor lung function as
if the lungs have aged beyond the patient’s
chronological age. 9
Recently, Parkes, et al., 2010 and Kotz et al., 2011
10-11 demonstrated that using lung age to
communicate lung function to smokers in the
primary care setting enhances smoking
abstinence at one year, but these authors were
not able to demonstrate any negative impact of
normal lung age.
Ventilatory function tests can provide important
clinical information, yet they are vastly
underused. They are designed to provide
objective, quantifiable measures of lung function
which are used to evaluate and monitor disease
that affect heart and lung, including airflow
obstruction, restrictive disorders, exercise
limitation and bronchial hyperactivity and the
information obtained from these  tests  enable
the practitioner to recognize impairment , follow
the progress of disease, determine patient s’
responses to therapy, and to monitor the effect
of environmental, occupational and therapeutic
exposure. 12
Smoking is a community health problem which
unfortunately has become part of our youth
culture. The success of the community
interventions for smoking cessation and
changing smoking attitudes is to know the
priority of smoking as a public health problem
and to make efforts to limit and eradicate
smoking.
So the purpose of our study was to clarify the
adverse effects of smoking on lung age and
ventilatory function in adult Saudi students in
order to utilize it as an encouragement tool for
smoking cessation.
Subjects:
One Hundred Healthy, male, adult (aged 18 – 28
years) light smokers for more than two years
were eligible for study entry. Subjects were
excluded if they had diabetes mellitus, blood
pressure >160/95mmHg, or if they were on
medication, had any history of participating in
any regular exercise training for at least 4 months
prior to the study, or were participating in
another clinical trial.
Subjects were recruited via friends across the
University and signed the standard informed
consent form to participate in the study following
the consent of the Faculty Ethics Committee.
We actually start the study with 100 male
healthy subjects. All participants were assessed
using a structured pre tested respiratory
questionnaire to obtain their clinical and
anthropometric data. Unfortunately 19 subjects
dropped out and excluded from the study.
Study materials:
1- Standard weight and height scale (weight
scale, made in Germany) was used to measure
the weight and height of each participant and
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consequently the body mass index (BMI = weight
“kg”/height2"m2") was calculated. 13
2- Computerized pulmonary function testing
(PFA) apparatus (Carello Quark Cosmed SrI
pulmonary function test-Italy) was used to
evaluate Ventilatory function (FVC, FEV1, FEV1/
FVC, PEFR) and lung age among the participated
students (Figure 1).
Fig. 1: Cosmed PFT Apparatus.
Procedure:
Cosmed PFT apparatus preparation:
Calibration of the Cosmed PFT apparatus was
done daily before the measurement takes place,
then subject physical data [name, age (years),
height (cm), weight (kg)] was entered to allow
the Cosmed PFT apparatus flow screen to
calculate the predicted values.
Preparation of the subject:
The subjects to be tested were lightly clothed
and instructed not to eat before the test by 2
hours. The position of the subjects at the time
of the test was standing position, then learn the
subject what is meant by the various commands
“breathe naturally”, “take a deep breath” and
“blow all the air out” was necessary explained
before starting the test. The test was explained
to each patient individually in simple terms and
demonstrated for them before applying its steps.
At the beginning, subject’s name, age, weight,
height, race and sex were recorded in the
computerized Cosmed PFT apparatus. The
patient connected to flow sensor, then nose clip
was placed around the subject’s nose to prevent
air from passing through the nose during
application, then he put a new mouthpiece into
his mouth; it was held by the subject teeth and
enclosed firmly by the lips to prevent air leakage.
The patient then breathes few times normally
before the test done.
The maneuver was explained by the instructor
to the participants prior to testing (breathe
normally for several cycles, and then perform a
maximal inspiration, followed by a maximum
forced exhalation).
Subjects were asked to breathe at first normally
out of the mouthpiece. The instructor pressing
the start-button at the moment of the subject
is ready before start test. Then the subject was
asked to take a slow and deep inspiration to fill
his lungs completely with air and then expire
(blow out) as much as he can into the
mouthpiece, with nose clip is on. In order to
complete the FVC testing maneuver and meet
the acceptability and reproducibility criteria,
subjects must expel air forcibly and completed
in at least three attempts six seconds each
(Figure 2. A and B).
Fig. 2: Pulmonary function testing.
(A)
(B)
The measured values show the subject perfor-
mance of three successive trials on the
operator screen, then the best one was selected.
In this operating mode the device measures the
FVC, FEV1, FEV1/ FVC, PEFR and lung age.
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Statistical Analysis
Statistical analysis was conducted for this study
using SPSS software version 16. All values were
presented as a mean + standard deviation (SD).
Paired t-tests were used to assess any differences
in spirometric data collected before and after the
exercise and differences were considered
significant at p > 0.05.
Eighty-one smoker students from were enrolled
in this study. Their age ranged from 16 to 25
years with a mean of 23.88 + 2.7 years the height
ranged from 158.00 cm to 185.00 cm, with a
mean of 170.75 + 6.28 cm, and weight ranged
from 46.00 to 94.00 kg, with a mean of 72.32+
11.53 kg and BMI ranged from 16.3 to 33.12 kg/
m2 with a mean of 24.82 + 3.88 kg/m2. Table (1).
RESULTS AND TABLES
Table 1: General characteristics of the participating
students (mean + SD).
Character Mean SD
Age (years) 21.53 1.6
Weight (Kg) 72.32 11.53
Height (cm) 170.75 6.28







Ventilatory function, including (FVC, FEV1 and
PEFR) and lung age were evaluated for all
participants.
Paired t-test was applied to test the hypothesis
that there were non-significant differences
between the ventilatory function (FVC- FEV1-
FEV1/ FVC -PEFR) and lung age values obtained
from smoker students and those obtained from
predicted measures for normal; nonsmoker
students.
The results of the study showed the effect of
smoking on ventilatory function and lung age as
appeared in the differences between the
measured values for smokers and predicted
values for matched normal subjects.
The result revealed that there was a significant
decrease in the mean of FEV1 values in smokers’
students as compare with the predicted values
of normal, healthy matched subjects, as F-value
was (7.874) and p-value (0.006). Table (2) and
Figure (3).
The results showed non-significant differences
between the mean values of FVC in smokers’
students as compared with the predicted values
of normal, healthy matched subjects, as F-value
was (0) and p-value (0.989). Table (2) and Figure
(3).
Table 2: The Mean, SD and ‘t’ value with statistical









FVC 4.93 + 0.65 4.93 +  0.38 0 0.989**
FEV1 4.22 + 0.29 4.44 + 0. 63 7.874 0.006*
PEFR 548.42 + 127 575.86 + 63.31 3.027 0.084**
Lung age 23.88 + 2.7 21.51 + 1.7 44.871 0.000*
Level of significance at  P<0.05.  * = significant  ** = non-significant
As shown in table (2) and figure (4) there was
non-significant difference in mean value of PEFR
(L/min) when comparing the measured values
in smokers, students with the predicted values
of normal, healthy matched subjects;  F-value
was (3.027) and p-value (0.084).
The results showed a significant difference
between the mean values of  the lung age values
in smokers’ students as compared to the actual
age values, as F-value was (44.871) and p-value
(0.00). Table (2) and Figure (5).
Fig. 3: FVC and FEV1 mean values for smokers and
predicted non-smokers.
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Fig. 4: PEFR mean values for smokers and predicted
non-smokers.
Fig. 5: Lung age mean values for smokers and
predicted non –smokers.
DISCUSSION
This study was conducted to assess the impact
of smoking on ventilatory function and lung age
in sedentary smoking students. This study was
conducted on 81 volunteer smokers who agreed
to participate in the study, and was selected
randomly from a University students.
Forced expiratory volume in 1 sec. (FEV1) and
forced vital capacity (FVC) are measurements of
air forced out of the lungs. These measurements
are used to gauge the pulmonary function. 14
Our study provides a conclusion about the
difference between the ventilatory function and
lung age of smoker students compared to
non-smoker students. The study proves the
association of smoking with deterioration of lung
functions and lung aging.
Results of ventilatory function and lung age of
smokers’ students were compared with
predicted values for normal matched
non-smokers and showed significant difference
in the FEV1, PEFR and lung age between the
smoker students’ values and predicted normal
values. On the contrary; the study revealed
non-significant difference in FVC between the
smokers and non-smokers.
Cigarette smoking has been identified to be the
most important determinant of ventilatory
impairment 15.  Smoking impairs the growth of
forced expiratory volume in one second (FEV1)
in children16 and cause an accelerated decline in
FEV1, in adults. 15, 17
The concept of “lung age” (the age of the
average person who has an FEV1 equal to the
individual) was developed as a way of making
spirometry data easier to understand and also
as a potential psychological tool to show smokers
the apparent premature ageing of their lungs. 18
Abnormal lung age is a clear message that the
lungs are undergoing accelerated deterioration
that would be slowed if the smoker stopped19.
Lung age is a way of conceptualizing the
deterioration of lung function and a way of
expressing lung damage rather than using
mathematical concepts of a percentage of the
expected value of FEV1 for height, age and
gender. 20
The results of this study showed clearly that
ventilatory function; specifically FEV1;
significantly deteriorate in smokers students.
Furthermore; smokers’ lungs showed more
advanced age than matched normal non-
smokers. Walter et al., 21 found that Adult
smokers experience faster longitudinal
pulmonary function decline than nonsmokers
and that this accelerated decline returns to the
normal rate of aging-related decline following
smoking cessation, even if the cessation is
intermittent. 21
The results of this study concerning ventilatory
function were previously supported by a study
by Jawed et al., 17 indicated the association of
smoking with deterioration of lung functions as
well as the number of cigarettes smoked/
day.These results were further supported by a
cross-sectional survey among the 20 to 40 years
old smokers that showed association of cigarette
smoking with deterioration in FEV1/FVC ratio
and the onset of respiratory complaints which
was dosed dependent. 22
The significant differences between smokers’
ventilatory function and non-smokers’ predicted
values  were supported by a study showed that
there are the significant difference in the mean
spirometric values of FEV1/FVC of the smokers
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and the non-smokers of age 18-30 years.23
Viegi et al., 24 also showed that the prevalence
of pathological pulmonary function tests is
significantly higher in males and in subjects
exposed to active and/or passive smoking. . The
reduction of FVC may be an early marker of the
morphological changes first occurring in the
small airways of subjects exposed to smoke.
The decrease in FVC reflects a small airway
narrowing, with gas trapping, determined by loss
of elastic load or airway thickening whereas the
decrease in FEV1 reflects smooth muscle
contraction in the large airways. 25
Furthermore, the results of deteriorated
smoker’s  PEFR in this study were supported by
a study by Willemse et al., 26 that clearly found
lower  FVC, FEV1 and mid-expiratory flow rate
(FEF25-75) in smokers as compared to non-
smokers.26
Deteriorated ventilatory function observed in
smokers can be further explained on the basis
of the defensive lung reflex in response to
smoking; resulting in narrowing of the airways
and a consequent rise in airway resistance. 27
Another explanation for abnormal smoker’s
ventilatory function is that the smoking of
cigarettes by humans is believed to cause
oxidative stress by several mechanisms,
including direct damage by radical species and
the inflammatory response induced by smoking.
Oxidative stress was found to cause apoptosis
and lung injury. 28,29
Smoking induces an oxidative burden by
disturbing the oxidant- antioxidant balance and
leads to cellular damage in the lungs. Oxidative
stress caused by cigarette smoking can result in
the destruction of the alveolar wall, leading to
airway enlargement. Moreover, increased
oxidative stress can trigger proinflammatory
cytokines, which are increased in the lungs of
smokers. 30
Substantial evidence suggests the accelerated
decline of lung function in cigarette smokers’
results from smoke-induced inflammatory
processes. Inflammation begins with an
increased number of macrophages in the first
and second generation respiratory bronchioles.
21
Airway epithelial cells (AEC) are important
regulators of inflammation in the airway. They
have a function in host defense and play a
significant role in airway inflammation by
releasing NO, a potentially important mediator
of airway inflammation, as well as releasing
other mediators and recruiting inflammatory
cells. Cigarette smoke interferes with and
inhibits the normal function of AEC by a variety
of mechanisms. Some of these include decreases
in the level of exhaled NO, enhanced release of
pro-inflammatory cytokines, and inhibition of
the airway repair process.31
Exposure to cigarette smoke activates an
inflammatory cascade in the airway epithelium,
resulting in the production of a number of potent
cytokines and chemokines, with accompanying
damage to the lung epithelium, increased
permeability, and recruitment of macrophages
and neutrophils to the airway. 32
A positive association between pulmonary
surfactant and airway diameter has been
described; surfactant proteins were observed to
inhibit pulmonary inflammation. Production of
particular surfactant proteins is inhibited by
tobacco smoking. 21
CONCLUSION
The  results of the present study clarify the
deteriorating effects of smoking on lung
functions and showed that the ventilatory
function of smoker students are significantly
lower than the predicted ventilatory function of
age matched non-smoker subjects.
Furthermore; smoker lung tends to be older than
age matched non-smoker subject.
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